Skip to main content

Capula Management Ltd

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1557017 Grand Cayman, E9

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
13 quarters on record

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Mar 31, 2026
CallValue
$154,528
CallShares
200
PutValue
$386,320
PutShares
500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Capula Management Ltd holds $20,797,683 across 4 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $386,320 500
2026-03-31 $154,528 200
2025-12-31 $385,935 500
2025-12-31 $231,561 300
2025-09-30 $101,770 181
2025-09-30 $224,908 400
2025-09-30 $168,681 300
2025-06-30 $157,500 300
2025-06-30 $105,000 200
2025-06-30 $126,000 240
2025-03-31 $121,137 191
2025-03-31 $190,269 300
2024-09-30 $210,248 200
2024-09-30 $35,742 34
2024-09-30 $210,248 200
2024-03-31 $59,674 62
2024-03-31 $192,498 200
2023-12-31 $432,996 493
2023-09-30 $1,645,920 2,000
2023-09-30 $437,814 532
2022-12-31 $10,245,158 14,200
2022-09-30 $2,824,367 4,100
2022-03-31 $10,476,300 15,000
2022-03-31 $12,222,350 17,500
2021-03-31 $6,340,076 13,400
2021-03-31 $425,826 900
2021-03-31 $4,393,578 9,286